Bashir A, Lipton RB, Ashina S, Ashina M Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 2013 Oct 1;81(14):1260-8. doi: 10.1212/WNL.0b013e3182a6cb32. Epub 2013 Aug 28.
Choi KS, Lee JH, Yi HJ, Chun HJ, Lee YJ, Kim DW Incidence and risk factors of postoperative headache after endovascular coil embolization of unruptured intracranial aneurysms. Acta Neurochir (Wien). 2014 Jul;156(7):1281-7. doi: 10.1007/s00701-014-2095-8. Epub 2014 May 7. Erratum In: Acta Neurochir (Wien). 2014 Sep;156(9):1829.
Edvinsson L, Linde M New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet. 2010 Aug 21;376(9741):645-55. doi: 10.1016/S0140-6736(10)60323-6. Epub 2010 Apr 21.
Hazard E, Munakata J, Bigal ME, Rupnow MF, Lipton RB The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health. 2009 Jan-Feb;12(1):55-64. doi: 10.1111/j.1524-4733.2008.00404.x. Epub 2008 Jul 30.
Olesen J The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008 Nov;120(2):157-71. doi: 10.1016/j.pharmthera.2008.08.003. Epub 2008 Aug 23.
Schoenen J Hypoxia, a turning point in migraine pathogenesis? Brain. 2016 Mar;139(Pt 3):644-7. doi: 10.1093/brain/awv402. No abstract available.
Shevel E The extracranial vascular theory of migraine--a great story confirmed by the facts. Headache. 2011 Mar;51(3):409-417. doi: 10.1111/j.1526-4610.2011.01844.x.
Shevel E The extracranial vascular theory of migraine: an artificial controversy. J Neural Transm (Vienna). 2011 Apr;118(4):525-30. doi: 10.1007/s00702-010-0517-1. Epub 2011 Jan 5.
Shevel E The trigeminovascular system--quo vadis? Headache. 2009 May;49(5):785-6. doi: 10.1111/j.1526-4610.2009.01415.x. No abstract available.
Starling AJ, Dodick DW Best practices for patients with chronic migraine: burden, diagnosis, and management in primary care. Mayo Clin Proc. 2015 Mar;90(3):408-14. doi: 10.1016/j.mayocp.2015.01.010.
Stoeckelhuber BM, Suttmann I, Stoeckelhuber M, Kueffer G Comparison of the vasodilating effect of nitroglycerin, verapamil, and tolazoline in hand angiography. J Vasc Interv Radiol. 2003 Jun;14(6):749-54. doi: 10.1097/01.rvi.0000079984.80153.5e.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.